PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825F0FQW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $37,445
Award facts
- Contract value 100% obligated
- $37,445.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $37,445.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on May 12, 2025, with an ultimate completion date of May 13, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and is executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion ceiling through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems globally.
This delivery order falls within AmerisourceBergen's established pharmaceutical prime vendor relationship with the DLA, which enables the company to fulfill medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract demonstrates the company's capability to execute on competitively awarded federal procurement requirements with firm fixed pricing and maintains alignment with DLA's strategic pharmaceutical supply chain initiatives. As a child contract under the larger SPE2DX IDC vehicle, this award reflects the company's ongoing role in supporting critical federal medical logistics operations.
Quick answers
Who was awarded contract SPE2D825F0FQW?
SPE2D825F0FQW was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on May 12, 2025.
How much is contract SPE2D825F0FQW worth?
The government has obligated $37,445 on SPE2D825F0FQW.
Is contract SPE2D825F0FQW an order under another contract?
Yes. SPE2D825F0FQW is a delivery order under SPE2DX22D0059, an indefinite delivery contract.
Was contract SPE2D825F0FQW competed?
The extent of competition for SPE2D825F0FQW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award